The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects
Crossref DOI link: https://doi.org/10.1007/s00125-016-4194-y
Published Online: 2017-01-11
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vettor, Roberto
Inzucchi, Silvio E.
Fioretto, Paola
License valid from 2017-01-11